Pfizer Inc (PFE)
Net profit margin
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 8,014,000 | 4,260,000 | -2,599,000 | -296,000 | 2,132,000 | 10,470,000 | 21,472,000 | 29,051,000 | 31,372,000 | 29,771,000 | 29,309,000 | 24,966,000 | 21,979,000 | 19,180,000 | 13,228,000 | 11,154,000 | 9,632,000 | 8,701,000 | 14,187,000 | 15,744,000 |
| Revenue (ttm) | US$ in thousands | 63,627,000 | 60,113,000 | 55,643,000 | 55,094,000 | 58,497,000 | 68,538,000 | 77,944,000 | 92,952,000 | 100,331,000 | 99,879,000 | 101,335,000 | 92,570,000 | 81,491,000 | 69,337,000 | 57,374,000 | 50,198,000 | 47,644,000 | 48,648,000 | 49,197,000 | 50,660,000 |
| Net profit margin | 12.60% | 7.09% | -4.67% | -0.54% | 3.64% | 15.28% | 27.55% | 31.25% | 31.27% | 29.81% | 28.92% | 26.97% | 26.97% | 27.66% | 23.06% | 22.22% | 20.22% | 17.89% | 28.84% | 31.08% |
December 31, 2024 calculation
Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $8,014,000K ÷ $63,627,000K
= 12.60%
Pfizer Inc's net profit margin has displayed varying trends over the given time period. Starting at 31.08% in March 2020, the margin decreased to 28.84% in June 2020, showing a slight decline. This decline continued to September 2020, dropping to 17.89%, indicating a significant decrease in profitability. However, there was a recovery by December 2020, with the net profit margin improving to 20.22%.
Subsequently, there was a further improvement in Pfizer's profitability, with the net profit margin increasing to 22.22% by March 2021 and 23.06% by June 2021. The positive trend continued, reaching 27.66% in September 2021 and 26.97% by December 2021.
From March 2022 to December 2022, Pfizer's net profit margin consistently increased, reaching 31.27% by the end of December 2022. However, there was a decline in profitability in the subsequent periods. The net profit margin dropped to 31.25% by March 2023, further decreasing to 27.55% by June 2023.
The downward trend continued over the following periods, with the net profit margin decreasing significantly to 15.28% by September 2023 and a substantial drop to 3.64% by December 2023. The profitability turned negative in the subsequent periods, with the net profit margin being -0.54% in March 2024 and -4.67% in June 2024.
There was a recovery in profitability by September 2024, as the net profit margin increased to 7.09%. This positive trend continued, with the margin further improving to 12.60% by December 2024.
In conclusion, Pfizer Inc's net profit margin experienced fluctuations over the analyzed period, showing both positive and negative trends in its profitability levels.
Peer comparison
Dec 31, 2024